Answers are grounded in this paper and cite their sources.
In this large, national sample of Medicare insured older adults, nearly three-quarters of patients adhered with a multi-target stool DNA order for colorectal cancer screening. These real-world data should inform further clinical and population health applications, reimbursement model simulations, and guideline-endorsed colorectal cancer screening strategies adherence.
No takes yet. Share an insight, caveat, or question.
Weiser et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: